X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/nbe-therapeutics-commences-first-clinical-study-of-anti-ror1-antibody-drug-conjugate-for-patients-with-solid-tumors-301158939.html